By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus is that Fluor's NuScale share conversion and Oklo's 4% drop are likely overreactions driven by retail sentiment and market noise, rather than fundamental changes in the SMR sector. However, there are concerns about potential funding friction for pre-revenue SMR firms and the possibility of internal NuScale delays that Fluor might have visibility into.
Risk: Funding friction for pre-revenue SMR firms due to sentiment-driven de-ratings and potential delays in licensing and adoption.
Opportunity: The broader nuclear tailwinds from AI-driven electricity demand could support valuations in the long term.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Investors in NuScale rival Oklo may be taking a cue from Fluor's action.
Both nuclear start-ups have seen their share prices soar this year, and large sums of "paper profit" are now at risk.
Fluor is taking steps that could permit it to sell a large chunk of its stake in NuScale Power.
Investors in NuScale rival Oklo may be taking a cue from Fluor's action.
Both nuclear start-ups have seen their share prices soar this year, and large sums of "paper profit" are now at risk.
Shares of Oklo (NYSE: OKLO), one of a handful of start-up nuclear companies aiming to commercialize small modular reactors, slid 4% through 12:25 p.m. ET Friday -- and not because of anything Oklo did wrong.
Instead, Oklo is falling because of something Fluor (NYSE: FLR) did right.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
Nuclear engineering powerhouse Fluor announced this morning that, in order to cut down on "volatility" in its earnings results, which have skyrocketed on required "pre-tax mark-to-market gains" in the value of the stock it owns in NuScale Power (NYSE: SMR), Fluor will convert 15 million of its Class B NuScale shares into Class A shares... that it can then sell.
The less NuScale Fluor owns, the less volatile its earnings numbers will look. And the more NuScale stock Fluor then sells, the more NuScale profits it can lock in and convert to cash.
So why is this bad news for Oklo, which isn't involved in Fluor's transactions? Simply for this reason: Oklo investors are watching Fluor take the first steps toward selling off a lot of its stake in NuScale, and they're probably wondering if Fluor has decided to "take profits" on its NuScale investment -- and whether they should do similarly.
That's a fair question to ask.
NuScale stock, after all, has gained an astounding 485% over the past year. But the 835% gain of Oklo stock over the past year makes NuScale's gains look almost modest. Neither company earns any profit to justify its high stock price, moreover, nor is either NuScale nor Oklo expected to become profitable for years.
Given all this, selling some NuScale stock now seems a prudent decision for Fluor... and selling some Oklo stock right now might be a good idea for you, too.
Before you buy stock in Oklo, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Oklo wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $625,254! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,090,257!
Now, it’s worth noting Stock Advisor’s total average return is 1,036% — a market-crushing outperformance compared to 181% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
*Stock Advisor returns as of July 29, 2025
Rich Smith has no position in any of the stocks mentioned. The Motley Fool recommends NuScale Power. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Fluor's NuScale actions reflect internal accounting goals more than a verdict on small modular reactor viability overall."
The article links Fluor's planned NuScale share conversion and potential sales directly to Oklo's 4% drop, framing both as overvalued pre-profit SMR plays ripe for profit-taking after 835% and 485% rallies. This connection is weak: Fluor is managing its own earnings volatility from mark-to-market gains, not commenting on sector fundamentals. Oklo's focus on advanced reactors and data-center power deals faces different execution risks than NuScale's first-mover regulatory path. Broader nuclear tailwinds from AI-driven electricity demand could support valuations longer than the piece implies, though any sustained selling pressure from similar large holders would test that thesis quickly.
Both firms remain years from meaningful revenue with no profits in sight, so any large-holder exit in the sector can trigger justified de-rating regardless of specific business-model differences.
"Fluor's share conversion is a tax/accounting optimization, not evidence of fundamental deterioration in NuScale's business prospects or Oklo's competitive position."
The article conflates two separate phenomena: Fluor's rational earnings-smoothing move (converting NuScale shares to reduce mark-to-market volatility) with a signal that NuScale is overvalued. But Fluor's action is *structural*, not *fundamental*. Fluor isn't saying NuScale's long-term thesis broke; it's saying quarterly earnings swings are ugly for a contractor's P&L. OKLO's 835% YTD gain versus NuScale's 485% does suggest retail euphoria, but the article offers zero evidence that either company's *commercial timeline* or *technology risk* has changed. Panic selling based on an accounting maneuver is the opposite of disciplined investing.
If Fluor—a sophisticated industrial partner with deep NuScale visibility—is suddenly concerned enough about downside to lock in gains and reduce exposure, that's a credible signal that internal confidence has shifted, even if the stated reason is 'earnings volatility.'
"Fluor's divestment is an accounting optimization for their own earnings volatility rather than a fundamental indictment of the SMR sector's growth potential."
The market's reaction to Fluor’s move is a classic case of retail sentiment misinterpreting institutional accounting. Fluor is shedding NuScale shares to reduce earnings volatility—a defensive move to clean up their balance sheet—not necessarily a signal of fundamental skepticism toward the SMR (Small Modular Reactor) sector. Oklo’s 4% dip is likely noise driven by retail investors conflating 'taking profits' with 'losing faith.' With Oklo trading at massive premiums based on future potential rather than current cash flow, the real risk isn't Fluor's portfolio management, but the regulatory and capital-intensive hurdles these companies face before they can actually deliver a single operational reactor to the grid.
If Fluor—a major industry insider with deep visibility into NuScale's operational progress—is choosing to liquidate, they may be signaling that the path to commercial viability is further away than the current speculative hype suggests.
"The immediate price action in Oklo is more about speculative hype in nuclear startups than tangible near-term catalysts, making the downside risk greater if licensing timelines slip."
While the article ties Oklo's 4% drop to Fluor's NuScale stake maneuver, the causality is weak and looks like market noise. Fluor’s conversion/sale aims to reduce earnings volatility, not necessarily signal a negative for Oklo. Oklo’s lofty multiples rest on speculative SMR prospects, not visible profitability, and key catalysts—licensing, customer pilots, and financing—are years out. Missing context includes regulatory timelines, project pipelines, capital needs, and how NuScale/Fluor actions affect Oklo’s access to capital or partnerships. The real risk is a sentiment-driven unwind if licensing or adoption delays persist, more than any one-off stake sale by Fluor.
But Fluor’s move could validate the long-run value of NuScale’s ecosystem; a temporary Oklo dip might be a buying opportunity if the broader nuclear tech narrative remains intact.
"Fluor-induced sentiment shifts can directly inflate capital costs and delay Oklo timelines via tighter equity raises."
Gemini flags regulatory and capital hurdles but misses the direct feedback loop: a Fluor-driven sentiment hit raises Oklo's cost of equity for the next licensing and prototype rounds. Pre-revenue SMR firms cannot absorb even temporary de-ratings without pushing back first-reactor dates by years. That funding friction is more immediate than broad nuclear demand tailwinds.
"Funding friction from sentiment is real, but Fluor's *internal* visibility into NuScale's regulatory progress matters more and remains opaque."
Grok's funding-friction argument is sharper than I credited. But it assumes Oklo's capital access deteriorates materially from a 4% dip—unproven. More pressing: neither Grok nor Gemini addressed whether Fluor's move *itself* signals internal NuScale delays. If Fluor has visibility into licensing timelines slipping, that's not just sentiment; it's material. The article doesn't say Fluor disclosed this, so we're speculating. That's the real gap.
"Fluor's divestment is a strategic signal of failing internal project milestones, not merely an accounting adjustment."
Claude, stop treating Fluor’s move as purely 'structural.' In the industrial sector, 'earnings volatility' is often a convenient euphemism for 'we don't want to hold this asset through the next negative milestone.' If Fluor truly believed in NuScale’s near-term commercial viability, they would manage the volatility through hedging or derivatives rather than outright liquidation. This isn't just accounting; it’s a strategic exit from a project that is failing to meet internal capital-return hurdles.
"Financing terms and the cost of capital—not stock moves—will determine Oklo’s timing; Fluor’s sale hints at tighter funding, potentially delaying pilots more than the article suggests."
Gemini overreads Fluor’s move as 'defensive'; it may still be a sign of capital discipline across the NuScale ecosystem, and that matters for Oklo because a tighter funding environment raises the cost of equity and delays pilots. The missing link is the actual financing terms and debt availability; until we see credible project finance lines, the valuation multiple on Oklo remains hostage to a long regulatory clock rather than micro-flows in stock holdings.
The panel consensus is that Fluor's NuScale share conversion and Oklo's 4% drop are likely overreactions driven by retail sentiment and market noise, rather than fundamental changes in the SMR sector. However, there are concerns about potential funding friction for pre-revenue SMR firms and the possibility of internal NuScale delays that Fluor might have visibility into.
The broader nuclear tailwinds from AI-driven electricity demand could support valuations in the long term.
Funding friction for pre-revenue SMR firms due to sentiment-driven de-ratings and potential delays in licensing and adoption.